Concepedia

Shuxiang Wu

SW

Statistics

Publications

8

Citations

342

H-Index

8

Active since

2018

Affiliations

Fujian Medical University(Current)

Shuxiang Wu is an author at Fujian Medical University specializing in life sciences, hepatic apoptosis, and signal transduction.

Publications per year

2018–2024

8

Publications

8

AKT activator SC79 protects hepatocytes from TNF-α-mediated apoptosis and alleviates <scp>d</scp>-Gal/LPS-induced liver injury

Zhen-Tang Jing, Wei Liu, Chaorong Xue et al. · American Journal of Physiology-Gastrointestinal and Liver Physiology · 2019 · 93 citations

, , +17

Small hepatitis B virus surface antigen promotes malignant progression of hepatocellular carcinoma via endoplasmic reticulum stress-induced FGF19/JAK2/STAT3 signaling

Shuxiang Wu, Shuangshuang Ye, Xiaohan Lin et al. · Cancer Letters · 2020 · 62 citations · Full text

, , +17

PI3K/AKT inhibitors aggravate death receptor-mediated hepatocyte apoptosis and liver injury

Wei Liu, Zhen-Tang Jing, Chaorong Xue et al. · Toxicology and Applied Pharmacology · 2019 · 38 citations

, , +16

A Novel AKT Activator, SC79, Prevents Acute Hepatic Failure Induced by Fas-Mediated Apoptosis of Hepatocytes

Wei Liu, Zhen-Tang Jing, Shuxiang Wu et al. · American Journal Of Pathology · 2018 · 37 citations · Full text

, , +16

Hepatitis B Spliced Protein (HBSP) Suppresses Fas-Mediated Hepatocyte Apoptosis via Activation of PI3K/Akt Signaling

Shuxiang Wu, Wannan Chen, Zhen-Tang Jing et al. · Journal of Virology · 2018 · 35 citations · Full text

, , +17

1–5 of 8